NF1 and malignant peripheral nerve sheath tumor: While our study did not meet final accrual and was not powered to detect differences in response rates between sporadic and NF1-associated MPNST, this chemotherapy regimen used resulted in disease stabilization in a majority of the patients, which is important in a highly aggressive tumor.